AMANDA REID: Open Payments
NPI 1265672877 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,136 in 17 payments from 9 companies in 2025. Trend: 2023 $1,123 · 2024 $363 · 2025 $1,136
Food & beverage: $1,136
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $446 |
| Daiichi Sankyo Inc. | 2 | $152 |
| Lilly USA, LLC | 1 | $122 |
| Eisai Inc. | 1 | $122 |
| SERVIER PHARMACEUTICALS LLC | 1 | $112 |
| bioMerieux Inc | 1 | $103 |
| Amgen Inc. | 1 | $47 |
| ABBVIE INC. | 1 | $16 |
| TerSera Therapeutics LLC | 1 | $15 |
Products named: IMFINZI, Enhertu, ZEPBOUND, Leqembi, Voranigo, FILMARRAY, VECTIBIX, EPKINLY.
Industry payments across FL — which companies pay providers there.
